Dr Lutz Heinemann
Neuss profile Institute directs international project to develop an artificial pancreas for diabetics by the profile of Institute for metabolic research in Neuss can continue to expand North Rhine-Westphalia’s status as an important centre of science of the European Union. Profile coordinates the scientific project \”AP@Home\”, which is supported by the EU with EUR 10.5 million since March 12. It has the development of an artificial pancreas to the target and is therefore especially diabetics, who must inject insulin several times a day currently due to their disease. Professor Dr Lutz Heinemann, co-founder of the profile Institute, will represent the project at international scientific events. In addition to profile four more European companies and seven prestigious universities to \”AP@Home\”. \”That we may coordinate this project, is a great honor for us and shows the excellent reputation of our Institute, the especially the founder Professor Dr.\” Heinemann and Dr.
Heise have built up over decades in the diabetes research\”, says Dr. Bernd Kuglin, who Institute runs the profile together with Dr. Tim Heise. A milestone in the treatment of diabetes despite extensive research of many different universities and research institutions could be developed so far still no useable artificial pancreas. While such an innovation could significantly improve the quality of life of many diabetics. Currently, patients with insulin-dependent diabetes must inject the metabolic hormone under the skin several times a day and thereby adapt the required dose to their current blood sugar value. Normally, the pancreas regulates blood sugar levels and releases insulin in adequate quantities. This function is however disturbed in diabetic patients, so that they do to the insulin itself the body depending on the course of the disease. The difficulty here is to estimate the required amount of insulin. Nasty blood through a stitch finger allows While a measurement of blood sugar levels, an accurate assessment of the necessary amount of insulin is however still difficult and relies mostly on the experience of diabetics.
